ID: ALA5268993

Max Phase: Preclinical

Molecular Formula: C37H31NO3

Molecular Weight: 537.66

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(C(=O)/C=C/c2ccc(C(=O)N3C/C(=C\c4ccccc4)C(=O)/C(=C/c4ccccc4)C3)cc2)cc1C

Standard InChI:  InChI=1S/C37H31NO3/c1-26-13-17-32(21-27(26)2)35(39)20-16-28-14-18-31(19-15-28)37(41)38-24-33(22-29-9-5-3-6-10-29)36(40)34(25-38)23-30-11-7-4-8-12-30/h3-23H,24-25H2,1-2H3/b20-16+,33-22+,34-23+

Standard InChI Key:  BEHSSTPSRGZDDZ-OGTGZXTISA-N

Associated Targets(Human)

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 20296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 537.66Molecular Weight (Monoisotopic): 537.2304AlogP: 7.39#Rotatable Bonds: 6
Polar Surface Area: 54.45Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 8.31CX LogD: 8.31
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: -0.48

References

1. Moreira J, Saraiva L, Pinto MM, Cidade H..  (2020)  Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies.,  192  [PMID:32172081] [10.1016/j.ejmech.2020.112177]

Source